| ID | 10048 |
| Vaccine Name | COVILO (BBIBP-CorV) |
| Disease Name | COVID-19 |
| Disease Classification | Respiratory |
| Virus Name | SARS-CoV-2 virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Inactivated |
| Vaccine Status | Approved |
| Manufacturer | Sinopharm, Beijing Institute of Biological Products |
| Year of Manufacturing | NA |
| Manufacturing Country | China |
| Age | NA |
| Dosage | NA |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | Inactivated SARS-CoV-2 virus |
| Description | Produced in vero cells |
| Approving Organisation | NMPA, WHO |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | Inactivated SARS-CoV-2 vaccine (Vero cell) |
| PMID | NA |
| Clinical Trial ID | NA |
| Reference Link | https://cdn.who.int/media/docs/default-source/immunization/covid-19/16-june-22080-sinopharm-vaccine-explainer-update.pdf?sfvrsn=ad833095_1&download=true |
| Additional Links | https://cdn.who.int/media/docs/default-source/immunization/covid-19/16-june-22080-sinopharm-vaccine-explainer-update.pdf?sfvrsn=ad833095_1&download=true
|